Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New orally active iron chelators.

× No keyword cloud information.

12 in total

1. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.

Authors: G J Kontoghiorghes; S Chambers; A V Hoffbrand
Journal: Biochem J Date: 1987-01-01 Impact factor: 3.857

2. Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.

Authors: M Amélia Santos; Marco Gil; Lurdes Gano; Sílvia Chaves
Journal: J Biol Inorg Chem Date: 2005-09-23 Impact factor: 3.358

Review 3. Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors: George J Kontoghiorghes
Journal: Int J Mol Sci Date: 2022-06-16 Impact factor: 6.208

4. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.

Authors: J Y Jeremy; G J Kontoghiorghes; A V Hoffbrand; P Dandona
Journal: Biochem J Date: 1988-08-15 Impact factor: 3.857

Review 5. Oral iron chelation: a review with special emphasis on Indian work on deferiprone (L1).

Authors: M B Agarwal
Journal: Indian J Pediatr Date: 1993 Jul-Aug Impact factor: 1.967

Review 6. Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors: George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal: Drug Saf Date: 2003 Impact factor: 5.606

7. Iron mobilization from ferritin using alpha-oxohydroxy heteroaromatic chelators.

Authors: G J Kontoghiorghes
Journal: Biochem J Date: 1986-01-01 Impact factor: 3.857

8. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors: G J Kontoghiorghes; M A Aldouri; A V Hoffbrand; J Barr; B Wonke; T Kourouclaris; L Sheppard
Journal: Br Med J (Clin Res Ed) Date: 1987-12-12

9. Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.

Authors: Armand Paauw; Maurine A Leverstein-van Hall; Kok P M van Kessel; Jan Verhoef; Ad C Fluit
Journal: PLoS One Date: 2009-12-29 Impact factor: 3.240

10. Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective.

Authors: Renzo Galanello
Journal: Ther Clin Risk Manag Date: 2007-10 Impact factor: 2.423